Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Kappos

Showing results (81-90 of 225) with videos related to

Pageof 23
Sort By:
Journal of Neurology|February 1, 1997
Strategies for optimizing MRI techniques aimed at monitoring disease activity in multiple sclerosis treatment trialsF Barkhof, M Filippi, D H Miller, et al.
Nature Medicine|October 4, 2000
Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. The Altered Peptide Ligand in Relapsing MS Study GroupL Kappos, G Comi, H Panitch, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|September 11, 2008
[Stress-related vertical double vision and ptosis]A M Palmowski-Wolfe, L Kappos, J Müller-Brand, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1991
Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelinesD H Miller, F Barkhof, I Berry, et al.
Neurology|December 11, 2002
Meningoradiculitis associated with giant cell arteritisU Roelcke, D Eschle, L Kappos, et al.
Neurology|July 2, 2010
Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosisM Mehling, R Lindberg, F Raulf, et al.
Neurology|July 29, 2011
Evaluation of soluble HLA-G as a biomarker for multiple sclerosisA Waschbisch, R Sandbrink, H-P Hartung, et al.
Magnetic Resonance in Medicine|June 1, 1995
Proton MRS of gadolinium-enhancing MS plaques and metabolic changes in normal-appearing white matterW Roser, G Hagberg, I Mader, et al.
Neurology|September 13, 2006
Relapses and subsequent worsening of disability in relapsing-remitting multiple sclerosisP J Young, C Lederer, K Eder, et al.
AJNR. American Journal of Neuroradiology|August 23, 2000
Serial proton MR spectroscopy of contrast-enhancing multiple sclerosis plaques: absolute metabolic values over 2 years during a clinical pharmacological studyI Mader, W Roser, L Kappos, et al.
Pageof 23

Showing results (81-90 of 225) with videos related to

Sort By:
Pageof 23
Journal of Neurology|February 1, 1997
Strategies for optimizing MRI techniques aimed at monitoring disease activity in multiple sclerosis treatment trialsF Barkhof, M Filippi, D H Miller, et al.
Nature Medicine|October 4, 2000
Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. The Altered Peptide Ligand in Relapsing MS Study GroupL Kappos, G Comi, H Panitch, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|September 11, 2008
[Stress-related vertical double vision and ptosis]A M Palmowski-Wolfe, L Kappos, J Müller-Brand, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1991
Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelinesD H Miller, F Barkhof, I Berry, et al.
Neurology|December 11, 2002
Meningoradiculitis associated with giant cell arteritisU Roelcke, D Eschle, L Kappos, et al.
Neurology|July 2, 2010
Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosisM Mehling, R Lindberg, F Raulf, et al.
Neurology|July 29, 2011
Evaluation of soluble HLA-G as a biomarker for multiple sclerosisA Waschbisch, R Sandbrink, H-P Hartung, et al.
Magnetic Resonance in Medicine|June 1, 1995
Proton MRS of gadolinium-enhancing MS plaques and metabolic changes in normal-appearing white matterW Roser, G Hagberg, I Mader, et al.
Neurology|September 13, 2006
Relapses and subsequent worsening of disability in relapsing-remitting multiple sclerosisP J Young, C Lederer, K Eder, et al.
AJNR. American Journal of Neuroradiology|August 23, 2000
Serial proton MR spectroscopy of contrast-enhancing multiple sclerosis plaques: absolute metabolic values over 2 years during a clinical pharmacological studyI Mader, W Roser, L Kappos, et al.
Pageof 23